1. Control of cardiovascular disease risk factors among patients with type II diabetes in a primary-care setting in Beijing.
- Author
-
Zuo HJ, Wang WH, Deng LQ, and Su JL
- Subjects
- Adult, Aged, Aged, 80 and over, Aspirin administration & dosage, Beijing epidemiology, Blood Glucose, Cholesterol, LDL blood, Cross-Sectional Studies, Diabetes Complications etiology, Diabetes Complications prevention & control, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 drug therapy, Dyslipidemias blood, Dyslipidemias etiology, Dyslipidemias prevention & control, Female, Glycated Hemoglobin analysis, Humans, Hypertension blood, Hypertension etiology, Hypertension prevention & control, Male, Middle Aged, Outcome and Process Assessment, Health Care statistics & numerical data, Primary Health Care methods, Risk Factors, Diabetes Complications epidemiology, Diabetes Mellitus, Type 2 complications, Dyslipidemias epidemiology, Hypertension epidemiology, Primary Health Care statistics & numerical data
- Abstract
The aim of this study was to assess the control of blood glucose, blood pressure (BP), serum low-density lipoprotein cholesterol (LDL-c), and other cardiovascular disease risk factors among patients with type II diabetes in a primary-care setting in Beijing. We performed a cross-sectional, multi-center survey of 4056 patients with type II diabetes aged ≥40 years. In total, 22.6% were current smokers, 10.8% often drank alcohol, 29.0% were obese, and 67.4% participated in adequate levels of physical activity. About 70% of patients reported comorbid hypertension or dyslipidemia. Of these, 70.8% were being treated for diabetes and 79.3% for hypertension; 20.5% were receiving statins and 28.5% aspirin. The proportions of patients achieving their therapeutic target were 52.6% for fasting plasma glucose, 58.2% for BP, and 33.0% for LDL-c. Only 11.1% achieved all three goals. Among 1960 (48.3%) patients with a record of hemoglobin A1C, 27.8% achieved the hemoglobin A1C target (<6.5%). These data suggest that blood glucose and BP were more likely to be well controlled than LDL-c, the likelihood of control of multiple risk factors is low, and that the statin and aspirin use should be intensified in patients with a substantial risk of cardiovascular disease., (Copyright © 2017 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF